Resmetirom Cost in the US: Price, Insurance Coverage & Affordability

by

For patients diagnosed with MASH (metabolic dysfunction-associated steatohepatitis), formerly known as NASH, one of the biggest questions is:

How much does resmetirom cost in the United States?

Resmetirom, sold under the brand name Rezdiffra, is the first FDA-approved treatment specifically for adults with noncirrhotic MASH with moderate to advanced liver fibrosis (F2–F3).

While this breakthrough treatment offers hope, the price of resmetirom in the USA can be a major concern, especially for patients without strong insurance coverage.

In this guide, we’ll break down:

  • resmetirom price in USA
  • monthly and yearly cost
  • insurance coverage for resmetirom
  • copay assistance programs
  • ways to reduce out-of-pocket costs

This article is designed to help patients and caregivers understand the real-world affordability of this fatty liver treatment.

What Is the Cost of Resmetirom in the US?

The cash price of resmetirom (Rezdiffra) in the United States is currently estimated at approximately:

  • $3,950 to $4,116 per month
  • $47,000 to $49,000 per year

These figures may vary slightly depending on the pharmacy, dosage, and location. (Medfinder)

A recent health-economic analysis also referenced an annual price of about $19,011/year for cost-effectiveness modeling, but real-world cash pharmacy pricing may be substantially higher depending on access route and insurance contracts. (JAMA Network)

Estimated Monthly Breakdown

Expense TypeApproximate Cost
Without insurance$3,950–$4,116/month
With commercial insurance$0–$500/month (varies)
With copay cardAs low as $0 for eligible patients

The topic “resmetirom cost without insurance” is one of the highest searched topic in this domain in the recen trends.

What Is the Cost of Resmetirom in the US? (Quick Answer)

The cost of resmetirom in the United States is approximately:

  • $3,950 to $4,116 per month (without insurance)
  • $47,000 to $49,000 per year
  • $25 to $500 per month (with insurance, depending on coverage)

Most patients require prior authorization, and eligible users may reduce costs significantly using copay assistance programs.

Does Insurance Cover Resmetirom?

One of the most searched terms is insurance coverage resmetirom.

The good news is that many US commercial insurance plans may cover Rezdiffra, but coverage often depends on:

  • diagnosis confirmation
  • fibrosis stage
  • prior authorization approval
  • specialist prescription
  • step therapy requirements

Most insurers require proof that the patient has:

  • MASH / NASH diagnosis
  • F2 or F3 fibrosis
  • supporting imaging or biopsy reports

Coverage is usually stronger when prescribed by a hepatologist, gastroenterologist, or liver specialist. (Medical News Today)

Prior Authorization Requirements

Insurance companies commonly require prior authorization (PA) before approving resmetirom.

This means your doctor must submit medical documentation such as:

  • FibroScan reports
  • liver biopsy results
  • elevated liver enzymes
  • fibrosis staging
  • previous lifestyle treatment attempts

Approval timelines can range from:

  • 3–7 business days
  • sometimes 2–3 weeks

Medicare and Medicaid Coverage

Many users also search for:

“Does Medicare cover resmetirom?”

Coverage under Medicare Part D depends on the specific plan formulary.

Some plans may cover it, while others may require:

  • higher tier copays
  • coinsurance percentages
  • prior authorization

Medicaid coverage varies by state.

Because formularies change regularly, patients should verify directly with their plan provider.

How Much Will You Pay With Insurance?

Out-of-pocket costs can vary significantly.

Typical ranges include:

Low Copay Plans

  • $25–$100/month

Mid-Tier Plans

  • $150–$400/month

High Deductible Plans

  • $500–$1,500/month initially

After meeting deductibles, monthly costs may drop substantially.

This wide pricing range makes it essential to target search phrases like:

  • resmetirom insurance copay
  • resmetirom cost with insurance
  • rezdiffra monthly cost USA

Manufacturer Savings Programs

Eligible commercially insured patients may qualify for copay savings cards from the manufacturer.

Some assistance programs may reduce cost to:

  • $0 per fill
  • or very low monthly copays

Patients without insurance may also explore:

  • patient assistance foundations
  • specialty pharmacy discount programs
  • manufacturer support services (Medical News Today)

Why Is Resmetirom So Expensive?

Many patients ask why the drug costs so much.

The reasons include:

1. First-in-Class Drug

Resmetirom is the first approved therapy for MASH, making it a premium specialty medication.

2. Specialty Liver Treatment

Drugs for advanced liver disease often command higher prices.

3. Research and Development Costs

Clinical trials for MASH therapies are expensive and lengthy.

4. Limited Competition

Currently, there are no widely approved direct competitors in this class.

Is Resmetirom Worth the Cost?

For patients with progressive liver fibrosis, untreated MASH can lead to:

  • cirrhosis
  • liver failure
  • transplant risk
  • cardiovascular complications

From a long-term perspective, preventing progression may reduce future medical costs.

However, an economic study noted that at current pricing, resmetirom may not meet conventional cost-effectiveness thresholds without improved pricing or stronger outcome data. (JAMA Network)

This makes it a valuable discussion point for both patients and clinicians.

Ways to Reduce Resmetirom Cost

Here are practical ways patients can improve affordability:

Use Manufacturer Copay Programs

Always check eligibility.

Compare Specialty Pharmacies

Prices can differ.

Ask for 90-Day Supply

Sometimes lowers refill costs.

Use Insurance Appeals

Denied prior authorization decisions can often be appealed.

Consult Patient Assistance Foundations

Nonprofit medication support programs may help.

Final Thoughts

The resmetirom price in the USA is undeniably high, especially for uninsured patients.

Current estimates suggest a cost of roughly $4,000 per month, though insured patients may pay significantly less depending on plan coverage and copay assistance. (Medfinder)

For many patients with MASH and fibrosis, insurance approval and manufacturer support programs can dramatically improve affordability.

As awareness of fatty liver disease grows, search volume for resmetirom cost and insurance coverage is likely to increase sharply, making this a strong SEO topic with excellent health AdSense RPM potential.

Frequently Asked Questions (FAQs)

1. How expensive is resmetirom without insurance?

Resmetirom costs nearly $4,000 per month without insurance, making it one of the higher-priced specialty liver medications in the US.

2. Why is resmetirom so costly?

It is a first-in-class FDA-approved treatment for MASH, with high research costs and limited competition.

3. Can I get resmetirom for free?

Some patients may pay $0 per month if eligible for manufacturer copay assistance programs.

4. Is resmetirom covered by Blue Cross or Aetna?

Many large insurers may cover it, but prior authorization is required, and coverage depends on your medical condition.

5. What is the cheapest way to get resmetirom?

The most affordable options include:

  • Copay savings cards
  • Insurance coverage
  • Patient assistance programs

The average resmetirom cost in the USA ranges from $3,950 to $4,116 per month without insurance. However, patients with insurance may pay as little as $25 to $500 monthly depending on coverage, prior authorization approval, and copay assistance eligibility.